7 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Pneumocystis pneumonia (PCP ... Mycobacterium tuberculosis ... #OIs #HIVAIDS # ... IDSA #management ... #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Pneumocystis pneumonia (PCP ... Mycobacterium tuberculosis ... #OIs #HIVAIDS # ... IDSA #management ... #pharmacology
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
characteristic features Clinical ... Diagnosis: Latent ... staining, NAA (PCR ... #TB #Diagnosis ... #Management #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
characteristic features Clinical ... Diagnosis: Latent ... staining, NAA (PCR ... #TB #Diagnosis ... #Management #Treatment
Myasthenia Gravis Overview

Myasthenia Gravis is an autoimmune disorder of the postsynaptic neuromuscular junction.  Ab to
Miller Fischer and PCB ... myasthenia Diagnosis ... precipitated by: Drugs, infection ... Myasthenia #Gravis #diagnosis ... #management #neurology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
specific questions to ask ... Skin exam for infection ... Change in clinical ... medical and surgical management ... stratification #diagnosis
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
Mycobacterium Tuberculosis ... and molecular diagnostic ... HIV-infected persons with clinical ... Prevention #Treatment #management ... #HIVAIDS #pharmacology